Healthcare & Medical Devices Global Published · instant download

Global Third-party Medical Central Sterile Supply Department Market Strategic Research Report

Global Third-party Medical Central Sterile Supply Department…
$3,500 USD
Global Third-party Medical Central Sterile Supply Department Market Strategic Research Report

By Type: Steam and Other Methods, Ethylene Oxide (EO) Sterilization, Irradiation Sterilization

By Application: Hospital, Clinic, Medical Beauty Institution, Other

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: STERIS plc, Getinge AB, SteriPro International Inc., Sotera Health Co., Zhongjin Irradiation Inc., Laoken Medical, Julikang, Jinghong, Sinopharm Jienuo, Jul Union

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2031
Length: 150 pages
Market size 2025
$1401
Million USD
Forecast CAGR
10.54%
2025-2031
Forecast 2031
$2556
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

Overview

The global third-party medical central sterile supply department (CSSD) market is valued at approximately USD 1,401 million in 2025 and is projected to reach about USD 2,557 million by 2031, a compound annual growth rate of 10.6% over 2026-2031. The market covers independent providers that clean, inspect, pack and sterilize reusable surgical and medical instruments for hospitals, clinics and other care settings, replacing or supplementing in-house sterile processing. Growth is well above the expansion in hospital procedure volumes because of a structural shift from in-house departments toward outsourced and hybrid models.

Asia Pacific is the growth engine, rising from about USD 495 million in 2025 to USD 1,145 million in 2031 at a 15.0% CAGR, led by China, where licensed third-party CSSD centres grew from 22 in 2020 to 103 in November 2024. North America (USD 400 million in 2025, 8.0% CAGR) and Europe (USD 384 million, 6.5% CAGR) are mature, accreditation-driven markets, while the Middle East and Africa and Latin America are earlier-stage and tied to private hospital expansion. The report also sets out bear, base and bull cases, with 2031 values of USD 2,169 million, USD 2,557 million and USD 3,001 million.

The study sizes realised, billable revenue from outsourced reprocessing of reusable instruments only. Contract sterilization of single-use devices for manufacturers is treated as an adjacent market and excluded. The market is segmented by sterilization method into steam and other methods, ethylene oxide (EO) and irradiation, and by application into hospital, clinic, medical beauty institution and other end users. It is value-based and does not model volumes.

Scope of the Global Third-party Medical Central Sterile Supply Department Market Strategic Research Report

This report provides market sizing and 2026-2031 forecasts by sterilization method, application, region and country, a regional and national outlook across 5 regions, an assessment of growth drivers and inhibitors including ethylene oxide regulation, competitive landscape analysis with profiles of 10 key operators, Porter's Five Forces, PESTLE and SWOT analysis, and long-term outlook to 2035.

Segment by Type

  • Steam and Other Methods
  • Ethylene Oxide (EO) Sterilization
  • Irradiation Sterilization

Segment by Application

  • Hospital
  • Clinic
  • Medical Beauty Institution
  • Other

Key Companies Profiled

STERIS plc, Getinge AB, SteriPro International Inc., Sotera Health Co., Zhongjin Irradiation Inc., Laoken Medical, Julikang, Jinghong, Sinopharm Jienuo and Jul Union.

Who Can Use This Report?

Sterile-processing and contract-sterilization operators, medical-device and equipment makers weighing a move into services, hospital and health-system procurement and supply-chain teams, private-equity and strategic investors assessing regional operator roll-ups, and consultants and advisers working on outsourcing, infection-control and EO-regulation questions.

Market snapshot

Global Third-party Medical Central Sterile Supply Department Market Strategic Research Report snapshot, 2025–2031

Source: Market Research Reports
Market size CAGR 10.54%
Regional growth momentum
Market share by segment
Key metrics
Base value
$1401
2025
Forecast
$2556
2031
CAGR
10.54%
2025–2031
Regions
5
global
Key companies
STERIS plcGetinge ABSteriPro International Inc.Sotera Health Co.Zhongjin Irradiation Inc.Laoken MedicalJulikangJinghong
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Steam and Other MethodsEthylene Oxide (EO) SterilizationIrradiation Sterilization
By Application
HospitalClinicMedical Beauty InstitutionOther

Table of contents

Click a chapter to expand
01Executive Summary
  • 1.1 Market Overview and Scope
  • 1.2 Market Size and Growth Outlook
  • 1.3 Key Findings
  • 1.4 Segmentation Insights
  • 1.4.1 By Sterilization Method
  • 1.4.2 By Application
  • 1.5 Regional Perspective
  • 1.6 Competitive Landscape
  • 1.7 Growth Drivers and Constraints
  • 1.8 Strategic Implications
  • 1.9 Data Notes and Limitations
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size in 2025
  • 2.1.3 Indicative Historical Development, 2022-2025
  • 2.1.4 Forecast to 2031
  • 2.1.5 Regional Forecast
  • 2.1.6 Forecast by Sterilization Method
  • 2.1.7 Forecast by Application
  • 2.1.8 Forecast Drivers and Confidence
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Steam and Other Methods
  • 3.1.3 Ethylene Oxide (EO) Sterilization
  • 3.1.4 Irradiation Sterilization
  • 3.1.5 Segment Outlook and Analytical Considerations
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Hospital
  • 4.1.3 Clinic
  • 4.1.4 Medical Beauty Institution
  • 4.1.5 Other
  • 4.1.6 Application Outlook and Analyst View
05Regional Market Forecast
  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 North America
  • 6.1.1 United States
  • 6.1.2 Canada
  • 6.1.3 Mexico
  • 6.1.4 Rest of North America
  • 6.2 Europe
  • 6.2.1 Germany
  • 6.2.2 France
  • 6.2.3 United Kingdom
  • 6.2.4 Italy
  • 6.2.5 Russia
  • 6.2.6 Rest of Europe
  • 6.3 Asia Pacific
  • 6.3.1 China
  • 6.3.2 Japan
  • 6.3.3 South Korea
  • 6.3.4 Southeast Asia
  • 6.3.5 India
  • 6.3.6 Australia
  • 6.3.7 Rest of Asia Pacific
  • 6.4 Middle East and Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East and Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Market Drivers
  • 7.1.2 Market Restraints
  • 7.1.3 Regulation and Standards
  • 7.1.4 Impact Assessment
  • 7.1.5 Opportunities & White-Space Analysis
  • 7.1.6 Analyst Perspective
08Key Company Profiles
  • 8.1 STERIS plc
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2025–2031)
  • 8.2 Getinge AB
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2025–2031)
  • 8.3 SteriPro International Inc.
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2025–2031)
  • 8.4 Sotera Health Co.
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2025–2031)
  • 8.5 Zhongjin Irradiation Inc.
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2025–2031)
  • 8.6 Laoken Medical
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2025–2031)
  • 8.7 Julikang
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2025–2031)
  • 8.8 Jinghong
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2025–2031)
  • 8.9 Sinopharm Jienuo
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2025–2031)
  • 8.10 Jul Union
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2025–2031)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation versus Fragmentation
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2025-2031
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 PESTLE Analysis
  • 11.1.1 Political
  • 11.1.2 Economic
  • 11.1.3 Social
  • 11.1.4 Technological
  • 11.1.5 Legal and Regulatory
  • 11.1.6 Environmental
  • 11.1.7 Analyst Perspective on the PESTLE Outlook
12SWOT Analysis
  • 12.1 SWOT Analysis
  • 12.1.1 Market-Level Strengths
  • 12.1.2 Market-Level Weaknesses
  • 12.1.3 Strategic Opportunities
  • 12.1.4 External Threats
  • 12.1.5 SWOT Synthesis and Strategic Implications
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Regionalization and Chain Operators
  • 13.1.2 Digital Traceability and Automation
  • 13.1.3 EO Regulation and Method Mix
  • 13.1.4 Regional Growth Outlook
  • 13.1.5 Long-Term Market Outlook (2032-2035)
  • 13.1.6 Forecast Considerations and Data Limitations
  • 13.1.7 Investment & Strategic Priorities

Tables and figures

  • 2.1 Exhibit 2.1: Forecast of Global (in USD Bn)
  • 2.2 Exhibit 2.2: Forecast of Global Market YoY Growth Rate & CAGR Summary (in %)
  • 2.3 Exhibit 2.3: Forecast of North America (in USD Bn)
  • 2.4 Exhibit 2.4: Forecast of Europe (in USD Bn)
  • 2.5 Exhibit 2.5: Forecast of Asia Pacific (in USD Bn)
  • 2.6 Exhibit 2.6: Forecast of Middle East and Africa (in USD Bn)
  • 2.7 Exhibit 2.7: Forecast of Latin America (in USD Bn)
  • 3.8 Exhibit 3.8: Forecast of Steam and Other Methods (in USD Bn)
  • 3.9 Exhibit 3.9: Forecast of Ethylene Oxide (EO) Sterilization (in USD Bn)
  • 3.10 Exhibit 3.10: Forecast of Irradiation Sterilization (in USD Bn)
  • 4.11 Exhibit 4.11: Forecast of Hospital (in USD Bn)
  • 4.12 Exhibit 4.12: Forecast of Clinic (in USD Bn)
  • 4.13 Exhibit 4.13: Forecast of Medical Beauty Institution (in USD Bn)
  • 4.14 Exhibit 4.14: Forecast of Other (in USD Bn)
  • 6.15 Exhibit 6.15: Forecast of North America (in USD Bn)
  • 6.16 Exhibit 6.16: Forecast of United States (in USD Bn)
  • 6.17 Exhibit 6.17: Forecast of Europe (in USD Bn)
  • 6.18 Exhibit 6.18: Forecast of Germany (in USD Bn)
  • 6.19 Exhibit 6.19: Forecast of France (in USD Bn)
  • 6.20 Exhibit 6.20: Forecast of United Kingdom (in USD Bn)
  • 6.21 Exhibit 6.21: Forecast of Italy (in USD Bn)
  • 6.22 Exhibit 6.22: Forecast of Rest of Europe (in USD Bn)
  • 6.23 Exhibit 6.23: Forecast of Asia Pacific (in USD Bn)
  • 6.24 Exhibit 6.24: Forecast of China (in USD Bn)
  • 6.25 Exhibit 6.25: Forecast of Japan (in USD Bn)
  • 6.26 Exhibit 6.26: Forecast of South Korea (in USD Bn)
  • 6.27 Exhibit 6.27: Forecast of Southeast Asia (in USD Bn)
  • 6.28 Exhibit 6.28: Forecast of Middle East and Africa (in USD Bn)
  • 6.29 Exhibit 6.29: Forecast of Latin America (in USD Bn)
  • 6.30 Exhibit 6.30: Forecast of Brazil (in USD Bn)

Frequently asked questions

What is the size of the global third-party medical central sterile supply department market?
Approximately USD 1,401 million in 2025, projected to reach approximately USD 2,557 million by 2031, a CAGR of 10.6% over 2026-2031 (10.5% over 2025-2031).
What does the market cover?
Independent providers that clean, inspect, pack and sterilize reusable surgical and medical instruments for hospitals, clinics, medical beauty institutions and other care settings. Contract sterilization of single-use devices for manufacturers is treated as an adjacent market and excluded.
Which region is growing fastest?
Asia Pacific, from about USD 495 million in 2025 to USD 1,145 million in 2031 at a 15.0% CAGR, led by China. North America grows at 8.0%, Europe at 6.5%, the Middle East and Africa at 11.0% and Latin America at 9.0%.
How is the market segmented?
By sterilization method (steam and other methods, ethylene oxide, irradiation) and by application (hospital, clinic, medical beauty institution, other). Steam and other methods are about 70% of 2025 value and hospitals about 86%.
Which application is growing fastest?
Medical beauty institutions, at about 20.4% CAGR from a small base, ahead of clinics at about 14.7% and hospitals at about 9.7%.
How does ethylene oxide regulation affect the market?
EO serves heat-sensitive instruments and carries the greatest regulatory exposure, including the US EPA 2024 emissions rule, which is under reconsideration. The report expects EO's share to erode and favours compliant, well-capitalised operators.
Which companies are profiled?
STERIS plc, Getinge AB, SteriPro International Inc., Sotera Health Co., Zhongjin Irradiation Inc., Laoken Medical, Julikang, Jinghong, Sinopharm Jienuo and Jul Union.
Does the report include volume data?
No. The report is value-based only, expressed in USD million, with 2025 as the base year and 2026-2031 as the forecast period.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

All data sources are cited within the report. View our full research methodology →
Select a license
from $3,500.00
Report License Type
Optional add-ons
Published · instant download
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.